Report Detail
Global Ready to Use Coagulase Plasma Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4660850 |
- 16 February, 2026 |
- Global |
- 122 Pages |
- GIR |
- Medical Devices & Consumables
According to our (Global Info Research) latest study, the global Ready to Use Coagulase Plasma market size was valued at US$ 268 million in 2025 and is forecast to a readjusted size of US$ 404 million by 2032 with a CAGR of 6.1% during review period.
In 2025, global production of ready to use coagulase plasma reached approximately 5.0 million units, based on an average market price of around US$ 52 per unit. Industry gross profit margins generally ranged from 45% to 65%, reflecting strong value contribution from biological raw materials, standardized preparation, and diagnostic reliability. Global production capacity in 2025 was estimated at about 6.25 million units, indicating sufficient supply capability to support routine microbiology testing demand.
Ready to use coagulase plasma is a prepared diagnostic reagent used for the rapid identification of coagulase-positive Staphylococcus species. It is supplied in a ready-to-use format, eliminating the need for reconstitution and ensuring consistent performance, convenience, and reduced handling variability in clinical laboratories.
The industrial chain includes upstream plasma raw materials, anticoagulants, stabilizers, and sterile packaging components. The midstream focuses on plasma processing, formulation, sterile filling, and quality control. Downstream applications mainly involve clinical microbiology laboratories, hospitals, diagnostic centers, and research laboratories.
The ready to use coagulase plasma market is growing steadily as clinical laboratories emphasize faster turnaround times and standardized diagnostic workflows. Demand is driven by routine screening for Staphylococcus aureus infections, increased testing volumes in hospital laboratories, and a preference for ready-to-use reagents that reduce preparation errors. Compared with traditional reconstituted plasma, ready to use formats improve operational efficiency and result consistency. Advances in plasma stabilization and sterile processing are extending shelf life and improving storage convenience. During 2026–2032, supported by stable clinical testing demand, laboratory workflow optimization, and ongoing replacement of manual preparation methods, the ready to use coagulase plasma market is expected to maintain stable growth in global diagnostic markets.
This report is a detailed and comprehensive analysis for global Ready to Use Coagulase Plasma market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Ready to Use Coagulase Plasma market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Ready to Use Coagulase Plasma market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Ready to Use Coagulase Plasma market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Ready to Use Coagulase Plasma market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Ready to Use Coagulase Plasma
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Ready to Use Coagulase Plasma market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pro-Lab Diagnostics, Thermo Fisher Scientific, BD, TCS Biosciences, Hardy Diagnostics, HiMedia Laboratories, Sigma-Aldrich, Mast Group, Oxoid Deutschland, Central Drug House, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Ready to Use Coagulase Plasma market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Free Coagulase
Bound Coagulase
Market segment by Source Type
Rabbit Plasma Coagulase Test
Human Plasma Coagulase Test
Market segment by Test Format
Tube Coagulase Plasma
Slide Coagulase Plasma
Market segment by Application
Medical
Biotechnology
Others
Major players covered
Pro-Lab Diagnostics
Thermo Fisher Scientific
BD
TCS Biosciences
Hardy Diagnostics
HiMedia Laboratories
Sigma-Aldrich
Mast Group
Oxoid Deutschland
Central Drug House
LABORCLIN
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Ready to Use Coagulase Plasma product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Ready to Use Coagulase Plasma, with price, sales quantity, revenue, and global market share of Ready to Use Coagulase Plasma from 2021 to 2026.
Chapter 3, the Ready to Use Coagulase Plasma competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ready to Use Coagulase Plasma breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Ready to Use Coagulase Plasma market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Ready to Use Coagulase Plasma.
Chapter 14 and 15, to describe Ready to Use Coagulase Plasma sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Ready to Use Coagulase Plasma Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Free Coagulase
- 1.3.3 Bound Coagulase
- 1.4 Market Analysis by Source Type
- 1.4.1 Overview: Global Ready to Use Coagulase Plasma Consumption Value by Source Type: 2021 Versus 2025 Versus 2032
- 1.4.2 Rabbit Plasma Coagulase Test
- 1.4.3 Human Plasma Coagulase Test
- 1.5 Market Analysis by Test Format
- 1.5.1 Overview: Global Ready to Use Coagulase Plasma Consumption Value by Test Format: 2021 Versus 2025 Versus 2032
- 1.5.2 Tube Coagulase Plasma
- 1.5.3 Slide Coagulase Plasma
- 1.6 Market Analysis by Application
- 1.6.1 Overview: Global Ready to Use Coagulase Plasma Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.6.2 Medical
- 1.6.3 Biotechnology
- 1.6.4 Others
- 1.7 Global Ready to Use Coagulase Plasma Market Size & Forecast
- 1.7.1 Global Ready to Use Coagulase Plasma Consumption Value (2021 & 2025 & 2032)
- 1.7.2 Global Ready to Use Coagulase Plasma Sales Quantity (2021-2032)
- 1.7.3 Global Ready to Use Coagulase Plasma Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Pro-Lab Diagnostics
- 2.1.1 Pro-Lab Diagnostics Details
- 2.1.2 Pro-Lab Diagnostics Major Business
- 2.1.3 Pro-Lab Diagnostics Ready to Use Coagulase Plasma Product and Services
- 2.1.4 Pro-Lab Diagnostics Ready to Use Coagulase Plasma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Pro-Lab Diagnostics Recent Developments/Updates
- 2.2 Thermo Fisher Scientific
- 2.2.1 Thermo Fisher Scientific Details
- 2.2.2 Thermo Fisher Scientific Major Business
- 2.2.3 Thermo Fisher Scientific Ready to Use Coagulase Plasma Product and Services
- 2.2.4 Thermo Fisher Scientific Ready to Use Coagulase Plasma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Thermo Fisher Scientific Recent Developments/Updates
- 2.3 BD
- 2.3.1 BD Details
- 2.3.2 BD Major Business
- 2.3.3 BD Ready to Use Coagulase Plasma Product and Services
- 2.3.4 BD Ready to Use Coagulase Plasma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 BD Recent Developments/Updates
- 2.4 TCS Biosciences
- 2.4.1 TCS Biosciences Details
- 2.4.2 TCS Biosciences Major Business
- 2.4.3 TCS Biosciences Ready to Use Coagulase Plasma Product and Services
- 2.4.4 TCS Biosciences Ready to Use Coagulase Plasma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 TCS Biosciences Recent Developments/Updates
- 2.5 Hardy Diagnostics
- 2.5.1 Hardy Diagnostics Details
- 2.5.2 Hardy Diagnostics Major Business
- 2.5.3 Hardy Diagnostics Ready to Use Coagulase Plasma Product and Services
- 2.5.4 Hardy Diagnostics Ready to Use Coagulase Plasma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Hardy Diagnostics Recent Developments/Updates
- 2.6 HiMedia Laboratories
- 2.6.1 HiMedia Laboratories Details
- 2.6.2 HiMedia Laboratories Major Business
- 2.6.3 HiMedia Laboratories Ready to Use Coagulase Plasma Product and Services
- 2.6.4 HiMedia Laboratories Ready to Use Coagulase Plasma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 HiMedia Laboratories Recent Developments/Updates
- 2.7 Sigma-Aldrich
- 2.7.1 Sigma-Aldrich Details
- 2.7.2 Sigma-Aldrich Major Business
- 2.7.3 Sigma-Aldrich Ready to Use Coagulase Plasma Product and Services
- 2.7.4 Sigma-Aldrich Ready to Use Coagulase Plasma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Sigma-Aldrich Recent Developments/Updates
- 2.8 Mast Group
- 2.8.1 Mast Group Details
- 2.8.2 Mast Group Major Business
- 2.8.3 Mast Group Ready to Use Coagulase Plasma Product and Services
- 2.8.4 Mast Group Ready to Use Coagulase Plasma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Mast Group Recent Developments/Updates
- 2.9 Oxoid Deutschland
- 2.9.1 Oxoid Deutschland Details
- 2.9.2 Oxoid Deutschland Major Business
- 2.9.3 Oxoid Deutschland Ready to Use Coagulase Plasma Product and Services
- 2.9.4 Oxoid Deutschland Ready to Use Coagulase Plasma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 Oxoid Deutschland Recent Developments/Updates
- 2.10 Central Drug House
- 2.10.1 Central Drug House Details
- 2.10.2 Central Drug House Major Business
- 2.10.3 Central Drug House Ready to Use Coagulase Plasma Product and Services
- 2.10.4 Central Drug House Ready to Use Coagulase Plasma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 Central Drug House Recent Developments/Updates
- 2.11 LABORCLIN
- 2.11.1 LABORCLIN Details
- 2.11.2 LABORCLIN Major Business
- 2.11.3 LABORCLIN Ready to Use Coagulase Plasma Product and Services
- 2.11.4 LABORCLIN Ready to Use Coagulase Plasma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.11.5 LABORCLIN Recent Developments/Updates
3 Competitive Environment: Ready to Use Coagulase Plasma by Manufacturer
- 3.1 Global Ready to Use Coagulase Plasma Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Ready to Use Coagulase Plasma Revenue by Manufacturer (2021-2026)
- 3.3 Global Ready to Use Coagulase Plasma Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Ready to Use Coagulase Plasma by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Ready to Use Coagulase Plasma Manufacturer Market Share in 2025
- 3.4.3 Top 6 Ready to Use Coagulase Plasma Manufacturer Market Share in 2025
- 3.5 Ready to Use Coagulase Plasma Market: Overall Company Footprint Analysis
- 3.5.1 Ready to Use Coagulase Plasma Market: Region Footprint
- 3.5.2 Ready to Use Coagulase Plasma Market: Company Product Type Footprint
- 3.5.3 Ready to Use Coagulase Plasma Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Ready to Use Coagulase Plasma Market Size by Region
- 4.1.1 Global Ready to Use Coagulase Plasma Sales Quantity by Region (2021-2032)
- 4.1.2 Global Ready to Use Coagulase Plasma Consumption Value by Region (2021-2032)
- 4.1.3 Global Ready to Use Coagulase Plasma Average Price by Region (2021-2032)
- 4.2 North America Ready to Use Coagulase Plasma Consumption Value (2021-2032)
- 4.3 Europe Ready to Use Coagulase Plasma Consumption Value (2021-2032)
- 4.4 Asia-Pacific Ready to Use Coagulase Plasma Consumption Value (2021-2032)
- 4.5 South America Ready to Use Coagulase Plasma Consumption Value (2021-2032)
- 4.6 Middle East & Africa Ready to Use Coagulase Plasma Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Ready to Use Coagulase Plasma Sales Quantity by Type (2021-2032)
- 5.2 Global Ready to Use Coagulase Plasma Consumption Value by Type (2021-2032)
- 5.3 Global Ready to Use Coagulase Plasma Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Ready to Use Coagulase Plasma Sales Quantity by Application (2021-2032)
- 6.2 Global Ready to Use Coagulase Plasma Consumption Value by Application (2021-2032)
- 6.3 Global Ready to Use Coagulase Plasma Average Price by Application (2021-2032)
7 North America
- 7.1 North America Ready to Use Coagulase Plasma Sales Quantity by Type (2021-2032)
- 7.2 North America Ready to Use Coagulase Plasma Sales Quantity by Application (2021-2032)
- 7.3 North America Ready to Use Coagulase Plasma Market Size by Country
- 7.3.1 North America Ready to Use Coagulase Plasma Sales Quantity by Country (2021-2032)
- 7.3.2 North America Ready to Use Coagulase Plasma Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Ready to Use Coagulase Plasma Sales Quantity by Type (2021-2032)
- 8.2 Europe Ready to Use Coagulase Plasma Sales Quantity by Application (2021-2032)
- 8.3 Europe Ready to Use Coagulase Plasma Market Size by Country
- 8.3.1 Europe Ready to Use Coagulase Plasma Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Ready to Use Coagulase Plasma Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Ready to Use Coagulase Plasma Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Ready to Use Coagulase Plasma Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Ready to Use Coagulase Plasma Market Size by Region
- 9.3.1 Asia-Pacific Ready to Use Coagulase Plasma Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Ready to Use Coagulase Plasma Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Ready to Use Coagulase Plasma Sales Quantity by Type (2021-2032)
- 10.2 South America Ready to Use Coagulase Plasma Sales Quantity by Application (2021-2032)
- 10.3 South America Ready to Use Coagulase Plasma Market Size by Country
- 10.3.1 South America Ready to Use Coagulase Plasma Sales Quantity by Country (2021-2032)
- 10.3.2 South America Ready to Use Coagulase Plasma Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Ready to Use Coagulase Plasma Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Ready to Use Coagulase Plasma Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Ready to Use Coagulase Plasma Market Size by Country
- 11.3.1 Middle East & Africa Ready to Use Coagulase Plasma Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Ready to Use Coagulase Plasma Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Ready to Use Coagulase Plasma Market Drivers
- 12.2 Ready to Use Coagulase Plasma Market Restraints
- 12.3 Ready to Use Coagulase Plasma Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Ready to Use Coagulase Plasma and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Ready to Use Coagulase Plasma
- 13.3 Ready to Use Coagulase Plasma Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Ready to Use Coagulase Plasma Typical Distributors
- 14.3 Ready to Use Coagulase Plasma Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Ready to Use Coagulase Plasma. Industry analysis & Market Report on Ready to Use Coagulase Plasma is a syndicated market report, published as Global Ready to Use Coagulase Plasma Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Ready to Use Coagulase Plasma market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
